Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Biocept Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 13 | 0 | −13 |
| Shares | 174.7K | 0 | −174.7K (−100.0%) |
| Value | $218.0K | $0 | −$218.0K (−100.0%) |
New holders (0)
Institutions that held Biocept Inc at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (13)
Institutions that held Biocept Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Alyeska Investment Group, L.P. | 117,647 | $147.1K |
| Virtu Financial LLC | 13,777 | $17.0K |
| Two Sigma Securities, LLC | 12,718 | $15.9K |
| Geode Capital Management, LLC | 10,504 | $13.1K |
| Susquehanna International Group, LLP | 10,406 | $13.0K |
| BlackRock Inc. | 5,261 | $6.58K |
| Tower Research Capital LLC (TRC) | 3,802 | $4.75K |
| Group One Trading, L.P. | 270 | $338 |
| UBS Group AG | 124 | $155 |
| Advisor Group Holdings, Inc. | 33 | $41 |
| US Bancorp | 18 | $23 |
| Wells Fargo & Company | 11 | $14 |
| Royal Bank of Canada | 115 | $0 |